Annual Meeting

Can probiotics change fish behavior?

Laurel Oldach
April 28, 2021
Fishery salmon lead charmed lives compared to their seafaring wild counterparts, but they still face some stresses. Juvenile fish are raised in freshwater tanks and later transferred to saltwater pens. That transition, already stressful, also adds new predators; at Yellow Island Aquaculture in British Columbia, harbor seals sometimes haunt the edges of pens, trying to take a bite out of an unsuspecting fish.
 
Chelsea Frank
As farmed salmon mature, they are transferred into salt-water pens like these at Yellow Island Aquaculture. "If you have more flexible fish, are they better able to cope with that transfer?" said Chelsea Frank.
According to Chelsea Frank, a graduate student in ecology and evolutionary biology who studies farmed Chinook salmon at Yellow Island, the fish are at an extra genetic disadvantage. Instead of two copies of the genome, they have three; hatcheries use special treatments to prevent eggs from getting rid of an extra haploid genome, the polar body, after being fertilized. Triploid fish tend to be larger and less aggressive than their diploid siblings, which is good for aquaculture. However, triploidy also has drawbacks: It compromises the fish’s immune systems and seems to make them less adaptable to stress.
Chelsea Frank
Chelsea Frank performs a fish brain dissection for later transcriptomic analysis.
 
Frank and her colleagues in Christina Semeniuk’s lab and comentor Daniel Heath’s lab at the University of Windsor in Ontario are trying to determine whether an unlikely intervention — a probiotic supplement in fish food — might help triploid Chinook salmon fare better. They’re starting with how the fish behave.
 
“Behavioral flexibility and sensitivity … would be an immediate measure for physiological (and neural genomic) change, given the connections between the gut–brain–behavior axis,” Semeniuk said.
  Frank tested how probiotic supplements added to fish food affected the way hundreds of fingerling diploid and triploid fish respond to novel stimuli such as a glass bead tossed into the tank, a predator-shaped dummy passing overhead and an approaching human researcher. She will present her work as part of the Genomics poster session during the 2021 ASBMB annual meeting; you can see her talk and post questions while the meeting is underway.  
 
In the future, Frank plans to integrate transcriptomic analyses with her behavioral studies, an approach known as behavioral genomics. Little is known about how triploidy affects genes related to learning and memory, so even if probiotics have little effect, she stands to learn something interesting.
 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Related articles

Biochemists bite back
Marissa Locke Rottinghaus
Building natural products
Yi Tang & Katherine Ryan
Living in a bubble
Y. Jessie Zhang & Ivaylo Ivanov

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Avoiding common figure errors in manuscript submissions
How-to

Avoiding common figure errors in manuscript submissions

Feb. 27, 2026

The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Journal News

Ragweed compound thwarts aggressive bladder and breast cancers

Feb. 26, 2026

Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.

Lipid-lowering therapies could help treat IBD
Journal News

Lipid-lowering therapies could help treat IBD

Feb. 25, 2026

Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.

Key regulator of cholesterol protects against Alzheimer’s disease
Journal News

Key regulator of cholesterol protects against Alzheimer’s disease

Feb. 24, 2026

A new study identifies oxysterol-binding protein-related protein 6 as a central controller of brain cholesterol balance, with protective effects against Alzheimer’s-related neurodegeneration.

From humble beginnings to unlocking lysosomal secrets
Award

From humble beginnings to unlocking lysosomal secrets

Feb. 20, 2026

Monther Abu–Remaileh will receive the ASBMB’s 2026 Walter A. Shaw Young Investigator Award in Lipid Research at the ASBMB Annual Meeting, March 7-10 in Washington, D.C.

Chemistry meets biology to thwart parasites
Award

Chemistry meets biology to thwart parasites

Feb. 19, 2026

Margaret Phillips will receive the Alice and C. C. Wang Award in Molecular Parasitology at the ASBMB Annual Meeting, March 7-10 in Washington, D.C.